ACL.AX
Price:
$3.01
Market Cap:
$593.34M
Australian Clinical Labs Limited provides pathology services in Australia. The company offers range of services, which include routine pathology test, advanced molecular genetics testing, harmony NIPT and first trimester screening, genetic carrier screening, chemical pathology, histopathology, and cytopathology; hematology, allergy, and immunology; serology and microbiology; and infectious molecular testing, cardiac testing services, functional pathology, veterinary pathology, and commercial drug and alcohol testing services. It offers its service to private and public hospitals. The company was incorporated in 2020 and is headquartered in Clayton, Australia.
Industry
Medical - Diagnostics & Research
IPO Date
2021-05-14
Stock Exchange
ASX
Ticker
ACL.AX
According to Australian Clinical Labs Limited’s latest financial reports and current stock price. The company's current ROE is 17.72%. This represents a change of 165.38% compared to the average of 6.68% of the last 4 quarters.
The mean historical ROE of Australian Clinical Labs Limited over the last ten years is -16.14%. The current 17.72% ROE has changed -209.73% with respect to the historical average. Over the past ten years (40 quarters), ACL.AX's ROE was at its highest in in the June 2020 quarter at 64.44%. The ROE was at its lowest in in the June 2018 quarter at -82.56%.
Average
-16.14%
Median
17.15%
Minimum
-170.17%
Maximum
76.68%
Discovering the peaks and valleys of Australian Clinical Labs Limited ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 23.27%
Maximum Annual ROE = 76.68%
Minimum Annual Increase = -255.81%
Minimum Annual ROE = -170.17%
Year | ROE | Change |
---|---|---|
2024 | 13.48% | -35.25% |
2023 | 20.82% | -72.85% |
2022 | 76.68% | 4.02% |
2021 | 73.72% | 23.27% |
2020 | 59.80% | -255.81% |
2019 | -38.38% | -76.76% |
2018 | -165.12% | -2.97% |
The current ROE of Australian Clinical Labs Limited (ACL.AX) is less than than its 3-year, less than than its 5-year, and greater than its 10-year historical averages
3-year avg
37.00%
5-year avg
48.90%
10-year avg
-16.14%
Australian Clinical Labs Limited’s ROE is greater than Acrux Limited (-179.09%), less than Antisense Therapeutics Limited (0%), greater than Healius Limited (-2.21%), greater than Starpharma Holdings Limited (-48.83%), less than Neuren Pharmaceuticals Limited (48.72%),
Company | ROE | Market cap |
---|---|---|
-179.09% | $9.37M | |
0% | $52.29M | |
-2.21% | $1.01B | |
-48.83% | $37.22M | |
48.72% | $1.43B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Australian Clinical Labs Limited using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Australian Clinical Labs Limited or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is Australian Clinical Labs Limited's ROE?
How is the ROE calculated for Australian Clinical Labs Limited (ACL.AX)?
What is the highest ROE for Australian Clinical Labs Limited (ACL.AX)?
What is the 3-year average ROE for Australian Clinical Labs Limited (ACL.AX)?
What is the 5-year average ROE for Australian Clinical Labs Limited (ACL.AX)?
How does the current ROE for Australian Clinical Labs Limited (ACL.AX) compare to its historical average?